possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept)

The FDA is warning about a possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept).

There are 30 reports of serious infections...including 6 deaths.

Enbrel works by binding tumor necrosis factor (TNF)...a protein that leads to joint pain and inflammation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote